Tuesday, December 23, 2025
News Health

News Health

Remibrutinib is the first Bruton tyrosine kinase inhibitor approved by the FDA for chronic spontaneous urticaria. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-oral-btk-inhibitor-chronic-spontaneous-2025a1000q9c?src=rss Author : Publish date : 2025-10-01 07:09:00...

Read more
Page 161 of 172 1 160 161 162 172

Categories

Archives

December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031